Daniel Knecht | Vice President, Clinical Strategy & Policy

Daniel Knecht, Vice President, Clinical Strategy & Policy, Aetna

A board-certified internist and a Fulbright scholar, Dr. Knecht has developed insights into the health care industry through experiences in pharmaceutical entrepreneurship, life science strategy consulting, patient care and population health research. Dr. Knecht currently serves as Vice President of Clinical Strategy and Policy for Aetna. His responsibilities include creation and execution of Aetna’s clinical strategy which enhances the value of health care afforded to members, as well as identifying and implementing strategic initiatives, in care management, and data analytics. Dr. Knecht also provides oversight over Aetna’s Clinical Policy unit, a team that reviews clinical evidence regarding novel technologies including therapeutics, devices and diagnostics and establishes our coverage policies under the medical benefit. He also serves as Chief of Staff to Dr. Harold Paz, Aetna’s Chief Medical Officer. After graduating with honors from Dartmouth College, Dr. Knecht received a joint M.D., M.B.A. from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. During his residency in internal medicine at Mount Sinai Hospital in New York City, he received the competitive “Advancing Clinical Excellence in Medicine” grant from the Department of Internal Medicine. Dr. Knecht is also the recipient of the “Silver Apple Teaching Award,” recognizing his commitment to medical education. Prior to joining Aetna, Dr. Knecht worked at Frankel Group, which was acquired by Huron Life Sciences; there he provided strategic counsel to leading life science companies on a range of business challenges. He performed market analyses, competitive intelligence projects and due diligence assessments on biotechnology and pharmaceutical assets in varying stages of development. As a Fulbright Scholar in medical sciences, Dr. Knecht performed research that explored health care deficiencies of the Bedouin community inhabiting the Negev region in Israel. Dr. Knecht is an associate clinical professor at Mount Sinai West (formerly known as Roosevelt Hospital) and still sees patients.


World Anti-Microbial Resistance Congress USA 2018 - Day 1 @ 11:30

How Aetna leverages federal, state, and private sector collaborations to promote antibiotic stewardship

  • Implementing data driven approaches to encourage behavior change among providers and consumers
  • Aetna, CDC, and State DOHs ‘nudging’ providers to promote evidence-based treatment practices for acute infections
  • Fostering innovative partnerships to reduce the incidence of hospital acquired infections and inappropriate prescribing
last published: 21/Sep/18 19:05 GMT

back to speakers